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R852agreement with this notion, Silva et al.
[12] observed that reprogramming of
fibroblasts from a 129/MF1 hybrid
strain of mice gives rise mostly
to partially reprogrammed iPSCs
that rarely progress to pluripotency
unless treated with 2i. Similarly, the
establishment of rat iPSCs requires 2i
culture.
What consequences might these
findings have for human ESC/iPSC
research? Human ESCs are
fundamentally different from mouse
ESCs in that they require bFgf and
Activin A for their stable propagation
[1]. Interestingly, exposure of mouse
blastocysts, ESCs or postimplantation
embryos to bFgf and Activin A gives
rise to so-called epiblast stem cells
(EpiSCs) [13,14], which are very similar
to human ESCs and seem to represent
a developmentally more advanced or
‘primed’ state compared with the more
primitive or ‘naive’ state ofmouse ESCs
[15]. The findings by Chu et al. [6] thus
raise the interesting possibility that
progression of epiblast cells towards
a germ-cell fate, either by enforced
expression of certain transcription
factors [1,9] or by exposure of cells
to germ-cell-inducing cytokines, might
be sufficient to derive stable naive
ESC/iPSC lines in humans and other
species. Recent exciting progress inidentifying molecules that coax
pluripotent cells into germ cellsmay aid
in these efforts [16].References
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Mitochondrial Uncoupling
and EngulfmentClearance of apoptotic cells by phagocytes avoids triggering an inflammatory
response. A new study reveals that phagocytes dissipate their mitochondrial
proton electrochemical gradient to allow for the ingestion of more apoptotic
corpses. Mitochondria are therefore involved in all aspects of apoptosis, from
its activation through to the phagocytosis of dead cells.Grazia M. Cereghetti
and Luca Scorrano
Sustained cell proliferation during
development, tissue renewal or in the
course of the immune response is
accompanied by the production of
excess or damaged cells that die by
apoptosis. The accumulation of these
cells may lead to tissue damage and
inflammation: specialized systems
therefore efficiently remove them [1,2].Phagocytes are deputed to the
clearance of apoptotic cells and are
able to engulf multiple cells in order to
adapt their ‘cleaning efficiency’ to the
rate of apoptotic cell accumulation.
In recent years, some of the crucial
steps in the phagocytosis of apoptotic
cells, as well as the principal players
in the phagocytic process, have been
elucidated [3,4]. Dying cells release
signals to attract the motile
phagocytes. The two cells makephysical contact via markers that are
released from the apoptotic cell and
bind to receptors on the phagocyte,
inducing a signaling cascade that
prepares the phagocyte membrane
for the internalization of the dead cell.
Several molecules are involved in
engulfment by phagocytes, including:
brain angiogenesis inhibitor 1 (BAI1),
a transmembrane protein highly
expressed in the brain; Rac GTPases,
which remodel the cytoskeleton;
ELMO, an evolutionarily conserved
cytoplasmic engulfment protein; and
the unconventional guanine nucleotide
exchange factor and Rho GTPase
activator Dock180 [5]. Despite our
knowledge of some key molecular
steps in the engulfment cascade,
how a single phagocyte can serially
internalize many apoptotic cells is
unclear. Park et al. [6] have now
shown, in a recent issue of Nature,
that serial internalization of apoptotic
cells unexpectedly depends on
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Figure 1. Apoptotic cell engulfment capacity relies on the mitochondrial membrane potential
(Dcm), which is influenced by Ucp2.
Internalization of apoptotic cells by phagocytes (1) is followed by phagocyte mitochondrial
membrane hyperpolarization (2), which blocks the engulfment of further cells. Upregulation
of Ucp2 (3) and dissipation of the proton gradient as a consequence of proton leak in the mito-
chondrial matrix (4) lowers Dcm (5), resulting in an as yet unidentified ‘continue-to-eat’ signal.
Dispatch
R853mitochondrial activity in the phagocyte,
and that a key player in this process
is uncoupling protein 2 (Ucp2) [6].
Mitochondria are important
organelles with several cellular
functions besides energy conversion,
ranging from metabolism to calcium
signaling to their key role in
amplification of apoptosis. Their
unique ability to efficiently synthesize
ATP depends on the accumulation of
free energy in the form of a proton
electrochemical gradient (Dm
w
H+ ) across
the inner mitochondrial membrane that
is then converted by the ATP synthase
into the chemical energy of the
thiophosphoric bond. The second law
of thermodynamics dictates that futile
dissipation of this gradient will result in
its conversion into other forms of
energy, such as thermal energy. Nature
clearly exploited this possibility in
a regulated fashion, by means of
uncoupling proteins. Ucp1, also known
as thermogenin, is a 32 kDa inner
mitochondrial membrane protein
present almost exclusively in brown
adipose tissue, where it participates
in thermogenesis by catalysing the
net transfer of protons from the
mitochondrial intermembrane space to
the matrix [7]. The Ucp1 homologue
Ucp2 is also a carrier for protons and
small molecules across the inner
mitochondrial membrane. Unlike Ucp1,
Ucp2 and Ucp3 are expressed in
multiple tissues, leading to questions
about their role: they have indeed been
reported to be involved in different
processes, such as modulation of
insulin secretion [8] and of
mitochondrial calcium uptake [9]. In
particular, functions attributed to Ucp2
are related to its ability to uncouple
ATP production from the proton
electrochemical gradient [10–13].
In the new study, Park et al. [6] asked
whether mitochondrial metabolism
could play a role in the phagocytosis
of apoptotic cells and analyzed the
mitochondrial membrane potential
(Dcm), i.e. the electrical component
of the Dm
w
H+ , in LR73 phagocytes
upon internalization of an apoptotic
cell. Surprisingly, Dcm increased
specifically when an apoptotic corpse
was being phagocytosed: other
synthetic targets did not alter Dcm,
in spite of a complete activation of the
engulfment machinery. While it is not
clear what drives this increase in Dcm,
its subsequent return to baseline is very
slow and is not connected to a net
increase in total cellular ATP levelsbut is associated with increased
expression of Ucp2.
Moreover, artificial overexpression
of Ucp2 increased the rate and
capacity of internalization by
phagocytes, suggesting a specific role
for Ucp2 and for dissipation of the
electrochemical gradient in this
process of increased ‘phagocytic
capacitance’ (Figure 1). Ravichandran
and coworkers [6] exclude that Ucp2
regulates phagocytosis by altering
production of reactive oxygen species
(ROS) or lipid oxidation [11] and
were able to recapitulate the
stimulation of phagocytosis by
using synthetic uncouplers like
2,4-dinitrophenol (2,4-DNP) and
carbonyl cyanide-4-(trifluoromethoxy)
phenylhydrazone (FCCP), further
substantiating the proposal that Ucp2
(unlike its homologues Ucp1 and Ucp3)
modulates phagocytosis via its primary
effect on Dm
w
H+ . While the result
strongly argues for a key role for
mitochondria in this process, it should
be noted that the synthetic uncouplers
have powerful side effects, and it is
surprising that the phagocytes can
survive upon complete uncoupling or
upon poisoning of the respiratory chain
with azide. It is likely that the excessglucose in the culture medium allows
cells to rely solely on glycolysis to
generate ATP. Would the role of Ucp2
(and of Dm
w
H+ ) be maintained under
more physiological conditions in which
mitochondria are used as the main ATP
source by the cell? A first answer to this
question comes from the analysis of
the effects of Ucp2 ablation on waste
elimination in tissues. Ucp2-/- mice
are viable but present higher ROS
production and altered macrophage-
mediated immunity [14]. The Dcm of
bone-marrow-derived macrophages
(BMDMs) from Ucp2-/- mice is higher
and these cells also have a decreased
ability to engulf apoptotic cells
compared with control cells.
Dexamethasone injection induces
rapid death of thymocytes in vivo [15],
followed by clearance of dead cells in
controlmice, but not inUcp2-/- animals.
Similarly, induction of germ cell
apoptosis via testicular torsion is
followed by accumulation of dying
germ cells in seminiferous tubules
in Ucp2-/- mice.
How is Ucp2 upregulated upon
engulfment of apoptotic corpses?
What is the mechanism granting
selectivity, i.e discriminating between
dead cells and other phagocytosed
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R854material? Overexpression of the
specific engulfment receptor Tim-4
improves the ability of phagocytes to
clear apoptotic cells [16–18] and this
also increases the upregulation of Ucp2
[6]. While the pathways emanating from
Tim-4 and leading to specific Ucp2
upregulation are at present unknown,
this piece of evidence connects
a plasma membrane receptor with
a specific metabolic event at the
mitochondrial level, showing that these
organelles are integrated with the
cellular signaling cascades.
The work by Ravichandran and
colleagues [6] adds a novel function
for mitochondria in the sequential
activation of the engulfment machinery
in phagocytes. We expect that this
paper will open new exciting avenues
of research that will address the many
questions raised by these findings. For
example, how is ingestion of apoptotic
cells coupled to the reported increase
in Dcm in phagocytes? How can
Ucp2 overexpression augment the
engulfment ability of these specialized
cells? Is this simply linked to energy
dissipation and heat generation, or is
it a consequence of the ensuing local
depletion of ATP that is consumed by
mitochondria in a futile attempt to
maintain their membrane potential
in the presence of a proton leak?
Ravichandran and colleagues [6] for
now help us in placing mitochondria
not only as key regulators of apoptosis
execution, but also as essentialmodulators of the clearance of
apoptotic cells.References
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DOI: 10.1016/j.cub.2011.09.007Developmental Biology: Physics Adds
a Twist to Gut LoopingMuch of the effort in understanding the dynamic process of development
has focused on dissecting biochemical pathways. Recent studies illustrate
that simple physical forces are also important in patterning organs.Rima Arnaout1,2,*
and Didier Y.R. Stainier1
‘‘Cell and tissue, shell and bone, leaf
and flower, are so many portions of
matter, and it is in obedience to the
laws of physics that their particles
have been moved, moulded and
conformed.’’
— D’Arcy Wentworth Thompson,
On Growth and Form (1917)
Nearly a century ago D’ArcyWentworth
Thompson argued that themorphological variations seen among
species obey basic physical and
mathematical laws (Figure 1). The
fantastic spectrum of form and
function has inspired the study of
allometry — differential growth of
tissues from a basic body plan — in
many contexts, from tree height to
the design of carnivores’ footpads
[1,2]. As different as these examples
are, all of these organisms start as
a single fertilized cell. Developmentis the process that exhibits the
dynamic movements and
morphological changes that underlie
Thompson’s observations. Over
more than one hundred years,
biologists have made considerable
progress in understanding
development. They have discovered
many biochemical regulatory
networks that are highly conserved
among species and that, taken
together, are beginning to provide
a coherent genetic blueprint
for development [3,4]. They
haven’t forgotten, however, that
development — and life — takes
place in a physical world and, as
Thompson wrote, obeys physical laws.
Examples can be seen in heart tube
looping, brain folding, airway
branching and gut looping [5–9].
